Stock NPCE NEUROPACE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages NeuroPace, Inc.

Equities

NPCE

US6412881053

Real-time Estimate Cboe BZX
Other stock markets
 03:26:52 2024-05-28 pm EDT 		5-day change 1st Jan Change
7.125 USD -5.38% Intraday chart for NeuroPace, Inc. -10.38% -30.89%
May. 13 Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating MT
May. 08 NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
NeuroPace, Inc. Reaffirms Earnings Guidance for the Year 2024
NeuroPace Shares Decline Following Q4 Financial Results
NeuroPace, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
NeuroPace, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
NeuroPace, Inc. Provides Earnings Guidance for the Year 2024
NeuroPace, Inc Announces Resignation of Irina Ridley as Chief Legal Officer and Corporate Secretary
NeuroPace Preliminary Q4 Revenue Beats Street View; Shares Rise
NeuroPace, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter Ended December 31, 2023
NeuroPace, Inc. Revises Revenue Guidance for the Full Year 2023
NeuroPace, Inc. Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
NeuroPace, Inc. to Leverage the Power of its RNS System?s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
NeuroPace, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
NeuroPace, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
NeuroPace, Inc. Revises Earnings Guidance for the Full Year 2023
NeuroPace Appoints Joel Becker as Chief Executive
Neuropace, Inc. Announces Board Member Changes
Neuropace, Inc. Announces Chief Executive Officer Changes
Exclusive-Musk's Neuralink valued at about $5 billion despite long road to market
EXCLUSIVA-Neuralink, de Musk, valorada en unos 5.000 millones de dólares pese a su largo camino hasta el mercado
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NPCE Stock
  4. News NeuroPace, Inc.
  5. Other languages